Search - tctmd.com

Displaying 421 - 440 of 509

Sort: Relevancy | Date

News Daily News

Las Recargas con Prasugrel son Viables tras un Pretratamiento con Clopidogrel en Pacientes víctimas de un SCA

Yael L. Maxwell

January 13, 2013

News Daily News

La Adenosina podría ser el Nexo de Unión entre el Ticagrelor y la Disnea

Caitlin E. Cox

January 09, 2013

News Daily News

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

Caitlin E. Cox

January 09, 2013

News Daily News

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

January 07, 2013

News Daily News

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

January 07, 2013

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

Pretratamiento con Clopidogrel Reduce los Episodios Cardíacos pero No la Mortalidad tras una PCI

Yael L. Maxwell

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

Yael L. Maxwell

December 19, 2012

Presentation

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Presenter: J. Yu

December 17, 2012

News Daily News

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Yael L. Maxwell

December 13, 2012

News Daily News

Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets

Jason Kahn

December 13, 2012

News Daily News

El Genérico Italiano Clopidogrel es Peor que la Marca Comercial en la Supresión Plaquetaria

Jason Kahn

December 13, 2012

News Daily News

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Yael L. Maxwell

December 13, 2012

News Daily News

Bivalirudina muestra ventaja con respecto a los GPI — pero no la heparina sola — en pacientes con STEMI

L.A. McKeown

November 28, 2012

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

News Conference News AHA 2012

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

November 05, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

News Daily News

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Jason Kahn

October 19, 2012

Advertisement

Las Recargas con Prasugrel son Viables tras un Pretratamiento con Clopidogrel en Pacientes víctimas de un SCA

La Adenosina podría ser el Nexo de Unión entre el Ticagrelor y la Disnea

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

Pretratamiento con Clopidogrel Reduce los Episodios Cardíacos pero No la Mortalidad tras una PCI

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets

El Genérico Italiano Clopidogrel es Peor que la Marca Comercial en la Supresión Plaquetaria

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Bivalirudina muestra ventaja con respecto a los GPI — pero no la heparina sola — en pacientes con STEMI

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content